Dengue fever treatment: Favorable Phase 1 clinical data presented at ASTMH meeting
by Press Release from Outbreak News Today on (#65EN1)
By NewsDesk @bactiman63 Clinical-stage biopharmaceutical company, Atea Pharmaceuticals, Inc., today presented a poster highlighting favorable AT-752 Phase 1 clinical data for the treatment of dengue fever at the American Society of Tropical Medicine & Hygiene (ASTMH) 2022 Annual Meeting in Seattle, Washington. The poster #1358, titled Safety, tolerability, and pharmacokinetics of AT-752, a novel nucleotide prodrug [...]
The post Dengue fever treatment: Favorable Phase 1 clinical data presented at ASTMH meeting appeared first on Outbreak News Today.